Godavari Drugs Other Announcement
Godavari Drugs filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing is a routine Regulation 31 disclosure with no transaction.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Godavari Drugs filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing is a routine Regulation 31 disclosure with no transaction.
Godavari Drugs Limited changed its Corporate Identification Number (CIN) following an alteration to its Memorandum of Association's Object Clause. The Ministry of Corporate Affairs registered the change on October 16, 2026.
Godavari Drugs Ltd filed its quarterly shareholding pattern as of June 30, 2026. The document provides a detailed breakdown of promoter and public holdings.
Godavari Drugs Limited filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms overall regulatory adherence with minor observations on historical filing delays.